Johnson & Johnson MedTech has agreed to sell its Acclarent portfolio of ear, nose and throat devices to Integra LifeSciences, which hopes to provide hardware for a range of procedures aimed at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback